Terms: = Breast cancer AND PSA
647 results:
1. An Immersive Virtual Reality Intervention for Preoperative Anxiety and Distress Among Adults Undergoing Oncological Surgery: Protocol for a 3-Phase Development and Feasibility Trial.
El-Gabalawy R; Sommer JL; Hebbard P; Reynolds K; Logan GS; Smith MSD; Mutter TC; Mutch WA; Mota N; Proulx C; Gagnon Shaigetz V; Maples-Keller JL; Arora RC; Perrin D; Benedictson J; Jacobsohn E
JMIR Res Protoc; 2024 May; 13():e55692. PubMed ID: 38743939
[TBL] [Abstract] [Full Text] [Related]
2. A lava-inspired proteolytic enzyme therapy on cancer with a PEG-based hydrogel enhances tumor distribution and penetration of liposomes.
Li J; Mi D; Wang R; Li Y; Zhao M; Shi S
J Nanobiotechnology; 2024 May; 22(1):216. PubMed ID: 38698399
[TBL] [Abstract] [Full Text] [Related]
3. Effect of Health Service Area on Primary Care Physician Provision of Low-Value cancer Screening.
Dindinger-Hill K; Horns J; Ambrose J; Vehawn J; Choudry M; Hunt TC; Chipman J; Haaland B; Li J; Hanson HA; O'Neil B
Ann Intern Med; 2024 May; 177(5):583-591. PubMed ID: 38648640
[TBL] [Abstract] [Full Text] [Related]
4. [Exploration and validation of optimal cut-off values for tpsa and fpsa/tpsa screening of prostate cancer at different ages].
Liu XM; Duan HY; Zhang DQ; Chen C; Ji YT; Zhang YM; Feng ZW; Liu Y; Li JJ; Zhang Y; Li CY; Zhang YC; Yang L; Lyu ZY; Song FF; Song FJ; Huang YB
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):354-364. PubMed ID: 38644271
[No Abstract] [Full Text] [Related]
5. A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate cancer Demonstrating "BRCAness" Genotype (ROAR).
Sahu KK; Li H; Mathew Thomas V; Benson M; Boucher K; Gupta S; Kohli M; Swami U; Agarwal N; Maughan BL
Oncologist; 2024 May; 29(5):450-e725. PubMed ID: 38452035
[TBL] [Abstract] [Full Text] [Related]
6. A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Wang Z; Ye J; Hu J; Zhang N; Yuan Y
J Cancer Res Clin Oncol; 2024 Mar; 150(3):110. PubMed ID: 38427070
[TBL] [Abstract] [Full Text] [Related]
7. The clinical association between coagulation indexes, platelet-related parameters, and bone metastasis of newly diagnosed prostate cancer.
Yu Z; Yuan M; Chen G
Eur J Med Res; 2023 Dec; 28(1):587. PubMed ID: 38093347
[TBL] [Abstract] [Full Text] [Related]
8. Latin America and the Caribbean Code Against cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening.
Baena A; Paolino M; Villarreal-Garza C; Torres G; Delgado L; Ruiz R; Canelo-Aybar C; Song Y; Feliu A; Maza M; Jeronimo J; Espina C; Almonte M
Cancer Epidemiol; 2023 Oct; 86 Suppl 1():102446. PubMed ID: 37852728
[TBL] [Abstract] [Full Text] [Related]
9. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract] [Full Text] [Related]
10. Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence.
Hou Y; Jiang KW; Wang LL; Zhi R; Bao ML; Li Q; Zhang J; Qu JR; Zhu FP; Zhang YD
Br J Cancer; 2023 Nov; 129(10):1625-1633. PubMed ID: 37758837
[TBL] [Abstract] [Full Text] [Related]
11. Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate cancer. A Systematic Review and Meta-analysis.
Fazekas T; Széles ÁD; Teutsch B; Csizmarik A; Vékony B; Kói T; Ács N; Hegyi P; Hadaschik B; Nyirády P; Szarvas T
Eur Urol Oncol; 2024 Jun; 7(3):365-375. PubMed ID: 37722977
[TBL] [Abstract] [Full Text] [Related]
12. What Is the Role of Nutraceutical Products in cancer Patients? A Systematic Review of Randomized Clinical Trials.
Di Napoli R; Balzano N; Mascolo A; Cimmino C; Vitiello A; Zovi A; Capuano A; Boccellino M
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513667
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-Darolutamide.
Podgoršek E; Mehra N; van Oort IM; Somford DM; Boerrigter E; van Erp NP
Clin Pharmacokinet; 2023 Aug; 62(8):1049-1061. PubMed ID: 37458966
[TBL] [Abstract] [Full Text] [Related]
14. Cost-effectiveness of sacituzumab govitecan versus chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer.
Xie J; Li S; Li Y; Li J
BMC Health Serv Res; 2023 Jun; 23(1):706. PubMed ID: 37386633
[TBL] [Abstract] [Full Text] [Related]
15. A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate cancer.
Pook D; Geynisman DM; Carles J; de Braud F; Joshua AM; Pérez-Gracia JL; Llácer Pérez C; Shin SJ; Fang B; Barve M; Maruzzo M; Bracarda S; Kim M; Kerloeguen Y; Gallo JD; Maund SL; Harris A; Huang KC; Poon V; Sutaria DS; Gurney H
Clin Cancer Res; 2023 Sep; 29(17):3292-3300. PubMed ID: 37339186
[TBL] [Abstract] [Full Text] [Related]
16. Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
Michalski JM; Winter KA; Prestidge BR; Sanda MG; Amin M; Bice WS; Gay HA; Ibbott GS; Crook JM; Catton CN; Raben A; Bosch W; Beyer DC; Frank SJ; Papagikos MA; Rosenthal SA; Barthold HJ; Roach M; Moughan J; Sandler HM
J Clin Oncol; 2023 Aug; 41(24):4035-4044. PubMed ID: 37315297
[TBL] [Abstract] [Full Text] [Related]
17. BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance.
Shu X; Li J; Chan UI; Su SM; Shi C; Zhang X; An T; Xu J; Mo L; Liu J; Wang Y; Li X; Deng M; Lei JH; Wang C; Tian H; Heng S; Shim JS; Zhang X; Dai Y; Yao Z; Kuang X; Lin Y; Deng CX; Xu X
Cancer Res; 2023 Aug; 83(15):2614-2633. PubMed ID: 37227919
[TBL] [Abstract] [Full Text] [Related]
18. Pseurotin A Validation as a Metastatic Castration-Resistant Prostate cancer Recurrence-Suppressing Lead via PCSK9-LDLR Axis Modulation.
Abdelwahed KS; Siddique AB; Ebrahim HY; Qusa MH; Mudhish EA; Rad AH; Zerfaoui M; Abd Elmageed ZY; El Sayed KA
Mar Drugs; 2023 Mar; 21(4):. PubMed ID: 37103355
[TBL] [Abstract] [Full Text] [Related]
19. Cost-effectiveness analysis of ovarian function preservation with GnRH agonist during chemotherapy in premenopausal women with early breast cancer.
Huang Y; Huang X; Huang X; Lin S; Luo S; Gu D; Weng X; Xu X
Hum Reprod; 2023 Jun; 38(6):1099-1110. PubMed ID: 37075316
[TBL] [Abstract] [Full Text] [Related]
20. Screening practices of cancer survivors and individuals whose family or friends had a cancer diagnoses-a nationally representative cross-sectional survey in Japan (INFORM Study 2020).
Akiyama M; Ishida N; Takahashi H; Takahashi M; Otsuki A; Sato Y; Saito J; Yaguchi-Saito A; Fujimori M; Kaji Y; Shimazu T;
J Cancer Surviv; 2023 Jun; 17(3):663-676. PubMed ID: 37041402
[TBL] [Abstract] [Full Text] [Related]
[Next]
